Sobetirome prodrug esters with enhanced blood–brain barrier permeability
- 1 November 2016
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 24 (22) , 5842-5854
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DK 052798, T32DK007680)
- OHSU Laura Fund for Innovation in Multiple Sclerosis
This publication has 44 references indexed in Scilit:
- Thyroid Hormone Actions in Cartilage and BoneEuropean Thyroid Journal, 2012
- Signals to promote myelin formation and repairNature Reviews Neurology, 2010
- Thyromimetics: a review of recent reports and patents (2004 – 2009)Expert Opinion on Therapeutic Patents, 2010
- Experimental hyperthyroidism in rats increases the expression of the ubiquitin ligases atrogin‐1 and MuRF1 and stimulates multiple proteolytic pathways in skeletal muscleJournal of Cellular Biochemistry, 2009
- Induction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimeticsThe Journal of Steroid Biochemistry and Molecular Biology, 2009
- The human brain endothelial cell line hCMEC/D3 as a human blood‐brain barrier model for drug transport studiesJournal of Neurochemistry, 2008
- Prodrug Approaches for CNS DeliveryThe AAPS Journal, 2008
- Structure−Brain Exposure RelationshipsJournal of Medicinal Chemistry, 2006
- Water soluble prodrug of a COX-2 selective inhibitor suitable for intravenous administration in models of cerebral ischemiaBioorganic & Medicinal Chemistry Letters, 2005
- Neurotrophic and Neuroprotective Actions of Estrogens and Their Therapeutic ImplicationsAnnual Review of Pharmacology and Toxicology, 2001